The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma
Authors
Keywords
Ovarian neoplasms, Serous carcinoma, Deleted in breast cancer 1, BRCA1, Prognosis
Journal
Journal of Ovarian Research
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-02-17
DOI
10.1186/s13048-015-0129-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA defective tumours: a study protocol
- (2015) Shibani Nicum et al. BMC CANCER
- CK2α phosphorylates DBC1 and is involved in the progression of gastric carcinoma and predicts poor survival of gastric carcinoma patients
- (2014) Jun Sang Bae et al. INTERNATIONAL JOURNAL OF CANCER
- Effect of BRCA1 immunohistochemical localizations on prognosis of patients with sporadic breast carcinomas
- (2014) Eleni Mylona et al. PATHOLOGY RESEARCH AND PRACTICE
- Expression of DBC1 and Androgen Receptor Predict Poor Prognosis in Diffuse Large B Cell Lymphoma
- (2014) Ho Sung Park et al. Translational Oncology
- SIRT1 expression is associated with a poor prognosis, whereas DBC1 is associated with favorable outcomes in gastric cancer
- (2014) Akira Noguchi et al. Cancer Medicine
- Reversing Platinum Resistance in High-Grade Serous Ovarian Carcinoma: Targeting BRCA and the Homologous Recombination System
- (2014) W. Ruprecht Wiedemeyer et al. Frontiers in Oncology
- Regulation of anoikis by deleted in breast cancer-1 (DBC1) through NF-κB
- (2013) Sun Hee Park et al. APOPTOSIS
- Deleted in breast cancer-1 (DBC-1) in the interface between metabolism, aging and cancer
- (2013) Eduardo Nunes Chini et al. BIOSCIENCE REPORTS
- Expression of nerve growth factor and heme oxygenase-1 predict poor survival of breast carcinoma patients
- (2013) Sang Jae Noh et al. BMC CANCER
- Deleted in breast cancer 1 (DBC1) deficiency results in apoptosis of breast cancer cells through impaired responses to UV-induced DNA damage
- (2013) Wootae Kim et al. CANCER LETTERS
- DBC1 is over-expressed and associated with poor prognosis in colorectal cancer
- (2013) Yongguo Zhang et al. International Journal of Clinical Oncology
- Acetylation status of P53 and the expression of DBC1, SIRT1, and androgen receptor are associated with survival in clear cell renal cell carcinoma patients
- (2013) Sang Jae Noh et al. PATHOLOGY
- Expression of SIRT1 and DBC1 Is Associated with Poor Prognosis of Soft Tissue Sarcomas
- (2013) Jung Ryul Kim et al. PLoS One
- BRCA1 Immunohistochemistry in a Molecularly Characterized Cohort of Ovarian High-Grade Serous Carcinomas
- (2012) Karuna Garg et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer
- (2012) Kelly L. Bolton JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- SIRT1 and c-Myc Promote Liver Tumor Cell Survival and Predict Poor Survival of Human Hepatocellular Carcinomas
- (2012) Kyu Yun Jang et al. PLoS One
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Androgen receptor expression is a biological marker for androgen sensitivity in high grade serous epithelial ovarian cancer
- (2011) Ahmed Elattar et al. GYNECOLOGIC ONCOLOGY
- The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop
- (2011) A. Menssen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of DBC1 as a transcriptional repressor for BRCA1
- (2010) H Hiraike et al. BRITISH JOURNAL OF CANCER
- Balance between SIRT1 and DBC1 expression is lost in breast cancer
- (2010) Ji-Youn Sung et al. CANCER SCIENCE
- Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma
- (2010) Ho Lee et al. HUMAN PATHOLOGY
- Deleted in breast cancer–1 regulates SIRT1 activity and contributes to high-fat diet–induced liver steatosis in mice
- (2010) Carlos Escande et al. JOURNAL OF CLINICAL INVESTIGATION
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
- (2010) Andrew Tutt et al. LANCET
- Expression of DBC1 and SIRT1 Is Associated with Poor Prognosis of Gastric Carcinoma
- (2009) E. J. Cha et al. CLINICAL CANCER RESEARCH
- Deleted in Breast Cancer 1, a Novel Androgen Receptor (AR) Coactivator That Promotes AR DNA-binding Activity
- (2009) Junjiang Fu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of SUV39H1 Methyltransferase Activity by DBC1
- (2009) Zhenyu Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A c-Myc–SIRT1 feedback loop regulates cell growth and transformation
- (2009) Jian Yuan et al. JOURNAL OF CELL BIOLOGY
- Expression and prognostic significance of SIRT1 in ovarian epithelial tumours
- (2009) Kyu Yun Jang et al. PATHOLOGY
- SIRT1 Expression is Associated With Poor Prognosis of Diffuse Large B-Cell Lymphoma
- (2008) Kyu Yun Jang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Negative regulation of the deacetylase SIRT1 by DBC1
- (2008) Wenhui Zhao et al. NATURE
- DBC1 is a negative regulator of SIRT1
- (2008) Ja-Eun Kim et al. NATURE
- Effect ofBRCA1/2Mutations on Long-Term Survival of Patients With Invasive Ovarian Cancer: The National Israeli Study of Ovarian Cancer
- (2007) Angela Chetrit et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started